Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.
Villanueva. Eneida E; Yalavarthi. Srilakshmi S; Berthier. Celine C CC; Hodgin. Jeffrey B JB; Khandpur. Ritika R; Lin. Andrew M AM; Rubin. Cory J CJ; Zhao. Wenpu W; Olsen. Stephen H SH; Klinker. Matthew M; Shealy. David D; Denny. Michael F MF; Plumas. Joel J; Chaperot. Laurence L; Kretzler. Matthias M; Bruce. Allen T AT; Kaplan. Mariana J MJ
Key Findings
- Low‑density granulocytes in lupus overproduce LL‑37 and other immune‑activating proteins
- These cells create more NETs that contain LL‑37, IL‑17, and DNA, which kill endothelial cells and boost interferon production
- NETs infiltrate lupus‑affected skin and kidneys and are associated with higher anti‑DNA antibodies
Practical Outcomes
- For the biohacker community, the main takeaway is that LL‑37 is part of harmful NETs in lupus, suggesting that strategies aimed at reducing NET formation or blocking LL‑37 could be therapeutic. However, the paper does not provide specific dosing, supplements, or protocols for implementation.
Summary
The study shows that a special type of neutrophil in lupus patients makes lots of a protein called LL‑37 and throws out web‑like structures (NETs) that damage blood vessels and trigger inflammation. These NETs are found in the skin and kidneys of lupus patients and are linked to higher disease markers. While this explains how LL‑37 may worsen lupus, it doesn’t give direct steps for healthy people to use.
Abstract
An abnormal neutrophil subset has been identified in the PBMC fractions from lupus patients. We have proposed that these low-density granulocytes (LDGs) play an important role in lupus pathogenesis by damaging endothelial cells and synthesizing increased levels of proinflammatory cytokines and type I IFNs. To directly establish LDGs as a distinct neutrophil subset, their gene array profiles were compared with those of autologous normal-density neutrophils and control neutrophils. LDGs significantly overexpress mRNA of various immunostimulatory bactericidal proteins and alarmins, relative to lupus and control neutrophils. In contrast, gene profiles of lupus normal-density neutrophils do not differ from those of controls. LDGs have heightened capacity to synthesize neutrophils extracellular traps (NETs), which display increased externalization of bactericidal, immunostimulatory proteins, and autoantigens, including LL-37, IL-17, and dsDNA. Through NETosis, LDGs have increased capacity to kill endothelial cells and to stimulate IFN-α synthesis by plasmacytoid dendritic cells. Affected skin and kidneys from lupus patients are infiltrated by netting neutrophils, which expose LL-37 and dsDNA. Tissue NETosis is associated with increased anti-dsDNA in sera. These results expand the potential pathogenic roles of aberrant lupus neutrophils and suggest that dysregulation of NET formation and its subsequent responses may play a prominent deleterious role.
Study Information
pubmed
2011
2011-05-25T00:00:00.000Z
10.4049/jimmunol.1100450
1166
72